Strategists at Commerzbank suspect that palladium is in the throes of basing and needs to go back on the radar. A break above the 1046 January 2020 high would open up the 200-day moving average (DMA) at 1122.
Platinum has based at 900
“Platinum has at last managed to erode its 55-day ma at 1000 and introduce scope to test 1046 the 2020 high.”
“It is showing signs of reversal from the 200-week ma at 930.77. The market has traded through here but the new low of 901.68 was not confirmed by the daily RSI and we suspect has based – the market charted a key week reversal a couple of weeks ago.”
“The market will need to regain 1046 (January 2020 high) to reassert upside dominance. This would allow for a deeper recovery to the 55-week ma at 1076.58 and the 200-day ma at 1122.”
“Only below 900 would allow for losses to the 871.75 61.8% retracement and potentially the 825 September 2020 low.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.